Related Articles
Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
Synergistic interaction between MEK inhibitor and gefitinib in EGFR‑TKI‑resistant human lung cancer cells
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway
3D cell culture alters signal transduction and drug response in head and neck squamous cell carcinoma